Search research articles
Contact Us
Filters
Showing results (851-860 of 864) with videos related to
Page
of 87
Sort By:
Acta Pharmacologica Sinica
|
July 27, 2022
A phase III randomized, double-blind, placebo-controlled trial of the denosumab biosimilar QL1206 in postmenopausal Chinese women with osteoporosis and high fracture risk
Hao Zhang, Jie-Mei Gu, Ai-Jun Chao, et al.
Cancer Cell
|
January 19, 2024
Refining the 8th edition TNM classification for EBV related nasopharyngeal carcinoma
Xiao-Jing Du, Gao-Yuan Wang, Xiao-Dong Zhu, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
November 22, 2021
SARS-CoV-2 Infection and COVID-19 Outcomes in Rheumatic Diseases: A Systematic Literature Review and Meta-Analysis
Richard Conway, Alyssa A Grimshaw, Maximilian F Konig, et al.
Cancer Communications (London, England)
|
October 26, 2021
The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma
Ling-Long Tang, Yu-Pei Chen, Chuan-Ben Chen, et al.
Lancet (London, England)
|
June 10, 2021
Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial
Yu-Pei Chen, Xu Liu, Qin Zhou, et al.
Nature Cancer
|
July 1, 2026
Long-term outcomes of adjuvant metronomic capecitabine in locoregionally advanced nasopharyngeal carcinoma: a randomized, controlled, multicenter, phase 3 study
Ya-Lan Tao, Dong-Hong Wu, Qin Zhou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 16, 2022
Final Overall Survival Analysis of Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma: A Multicenter, Randomized Phase III Trial
Yuan Zhang, Lei Chen, Guo-Qing Hu, et al.
Nature
|
March 12, 2026
Risk-adaptive therapy guided by dynamic ctDNA in nasopharyngeal carcinoma
Jiawei Lv, Dan-Xue Zheng, Jin-Hui Liang, et al.
The New England Journal of Medicine
|
June 1, 2019
Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma
Yuan Zhang, Lei Chen, Guo-Qing Hu, et al.
The Lancet. Oncology
|
September 4, 2025
Target volume delineation of the neck for radiotherapy in nasopharyngeal carcinoma: CSTRO, CACA, CSCO, HNCIG, ESTRO, and ASTRO guidelines and contouring atlas
Ling-Long Tang, Cheng-Long Huang, Shao-Jun Lin, et al.
Page
of 87
Search research articles
Search
Showing results (851-860 of 864) with videos related to
Sort By:
Page
of 87
Acta Pharmacologica Sinica
|
July 27, 2022
A phase III randomized, double-blind, placebo-controlled trial of the denosumab biosimilar QL1206 in postmenopausal Chinese women with osteoporosis and high fracture risk
Hao Zhang, Jie-Mei Gu, Ai-Jun Chao, et al.
Cancer Cell
|
January 19, 2024
Refining the 8th edition TNM classification for EBV related nasopharyngeal carcinoma
Xiao-Jing Du, Gao-Yuan Wang, Xiao-Dong Zhu, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
November 22, 2021
SARS-CoV-2 Infection and COVID-19 Outcomes in Rheumatic Diseases: A Systematic Literature Review and Meta-Analysis
Richard Conway, Alyssa A Grimshaw, Maximilian F Konig, et al.
Cancer Communications (London, England)
|
October 26, 2021
The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma
Ling-Long Tang, Yu-Pei Chen, Chuan-Ben Chen, et al.
Lancet (London, England)
|
June 10, 2021
Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial
Yu-Pei Chen, Xu Liu, Qin Zhou, et al.
Nature Cancer
|
July 1, 2026
Long-term outcomes of adjuvant metronomic capecitabine in locoregionally advanced nasopharyngeal carcinoma: a randomized, controlled, multicenter, phase 3 study
Ya-Lan Tao, Dong-Hong Wu, Qin Zhou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 16, 2022
Final Overall Survival Analysis of Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma: A Multicenter, Randomized Phase III Trial
Yuan Zhang, Lei Chen, Guo-Qing Hu, et al.
Nature
|
March 12, 2026
Risk-adaptive therapy guided by dynamic ctDNA in nasopharyngeal carcinoma
Jiawei Lv, Dan-Xue Zheng, Jin-Hui Liang, et al.
The New England Journal of Medicine
|
June 1, 2019
Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma
Yuan Zhang, Lei Chen, Guo-Qing Hu, et al.
The Lancet. Oncology
|
September 4, 2025
Target volume delineation of the neck for radiotherapy in nasopharyngeal carcinoma: CSTRO, CACA, CSCO, HNCIG, ESTRO, and ASTRO guidelines and contouring atlas
Ling-Long Tang, Cheng-Long Huang, Shao-Jun Lin, et al.
Page
of 87